NCT00741910 - Extension Study of Semapimod 60 mg IV x 3 Days | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Crohn's Disease

Interventions

DRUG

Semapimod

semapimod IV 60 mg x 3 days q 6 - 10 weeks

Trial Locations (8)

Asher Kornbluth, MD, New York

Long Island Clinical Research Associates, Great Neck

Northwestern University, Chicago

Benjamin Franklin University, Berlin

Rambam Medical Center, Haifa

Shaare Zedek Hospital, Jerusalem

Tel Aviv Sourasky Medical Center, Tel Aviv

Erasmus Medical Center, Rotterdam